COVID-19 and multisystem inflammatory syndrome in children and adolescents

2020, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145 Sanna, 2020, Children's heart and COVID-19: up-to-date evidence in the form of a systematic review, Eur J Pediatr, 179, 1079, 10.1007/s00431-020-03699-0 Jones, 2020, COVID-19 and Kawasaki disease: novel virus and novel case, Hosp Pediatr, 10, 537, 10.1542/hpeds.2020-0123 Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic, Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1 Balasubramanian, 2020, Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab, Indian Pediatr, 10.1007/s13312-020-1901-z Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X Toubiana, 2020, Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: prospective observational study, BMJ, 369 Rauf, 2020, Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic, Indian J Pediatr, 10.1007/s12098-020-03357-1 Chiotos, 2020, Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series, J Pediatric Infect Dis Soc, 9, 393, 10.1093/jpids/piaa069 Greene, 2020, Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C), Am J Emerg Med, 10.1016/j.ajem.2020.05.117 Grimaud, 2020, Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children, Ann Intensive Care, 10, 69, 10.1186/s13613-020-00690-8 Whittaker, 2020, Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, JAMA, 10.1001/jama.2020.10369 Cheung, 2020, Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City, JAMA, 10.1001/jama.2020.10374 Belhadjer, 2020, Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic, Circulation, 10.1161/CIRCULATIONAHA.120.048360 Dufort, 2020, Multisystem inflammatory syndrome in children in New York state, N Engl J Med, 383, 347, 10.1056/NEJMoa2021756 Feldstein, 2020, Multisystem inflammatory syndrome in U.S. children and adolescents, N Engl J Med, 383, 334, 10.1056/NEJMoa2021680 Hameed, 2020, Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, Radiology Kaushik, 2020, Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York City, J Pediatr, 10.1016/j.jpeds.2020.06.045 Capone, 2020, Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection, J Pediatr, 10.1016/j.jpeds.2020.06.044 Miller, 2020, Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases, Gastroenterology, 10.1053/j.gastro.2020.05.079 Riollano-Cruz, 2020, Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience, J Med Virol Blondiaux, 2020, Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series, Radiology, 10.1148/radiol.2020202288 Ng, 2020, COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection, J Med Virol, 10.1002/jmv.26206 Ouldali, 2020, Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis, Lancet Child Adolesc Health, 10.1016/S2352-4642(20)30175-9 Ramcharan, 2020, Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital, Pediatr Cardiol, 10.1007/s00246-020-02391-2 Schupper, 2020, Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19, Childs Nerv Syst, 36, 1579, 10.1007/s00381-020-04755-8 Pouletty, 2020, Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort, Ann Rheum Dis, 79, 999, 10.1136/annrheumdis-2020-217960 Rivera-Figueroa, 2020, Incomplete Kawasaki disease in a child with COVID-19, Indian Pediatr, 10.1007/s13312-020-1900-0 Waltuch, 2020, Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department, Am J Emerg Med, 10.1016/j.ajem.2020.05.058 Licciardi, 2020, SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children, Pediatrics, 10.1542/peds.2020-1711 Levin, 2020, Childhood multisystem inflammatory syndrome—a new challenge in the pandemic, N Engl J Med, 383, 393, 10.1056/NEJMe2023158 Kanegaye, 2009, Recognition of a Kawasaki disease shock syndrome, Pediatrics, 123, e783, 10.1542/peds.2008-1871 Newburger, 2004, Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, Circulation, 110, 2747, 10.1161/01.CIR.0000145143.19711.78 Gámez-González, 2013, Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children, Eur J Pediatr, 172, 337, 10.1007/s00431-012-1879-1 Chen, 2015, Clinical manifestations of Kawasaki disease shock syndrome: a case-control study, J Microbiol Immunol Infect, 48, 43, 10.1016/j.jmii.2013.06.005 Lin, 2015, Early differentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit, Pediatr Infect Dis J, 34, 1163, 10.1097/INF.0000000000000852 Yim, 2010, Coronary artery dilatation in toxic shock-like syndrome: the Kawasaki disease shock syndrome, Pediatr Cardiol, 31, 1232, 10.1007/s00246-010-9771-0 Gamez-Gonzalez, 2018, Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease, Pediatr Int (Roma), 60, 781, 10.1111/ped.13614 Matsubara, 2007, The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease, Curr Opin Infect Dis, 20, 298, 10.1097/QCO.0b013e3280964d8c Gatterre, 2012, Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome, Intensive Care Med, 38, 872, 10.1007/s00134-012-2473-8 Nagata, 2009, Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease, Immunology, 128, 511, 10.1111/j.1365-2567.2009.03135.x Dong, 2020, Epidemiology of COVID-19 among children in China, Pediatrics, 145, 10.1542/peds.2020-0702 Liu, 2020, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis, 20, 656, 10.1016/S1473-3099(20)30232-2 Yang, 2020, Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int J Infect Dis, 94, 91, 10.1016/j.ijid.2020.03.017 Götzinger, 2020, COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study, Lancet Child Adolesc Health, 10.1016/S2352-4642(20)30177-2 2020, Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020, MMWR Morb Mortal Wkly Rep, 69, 343, 10.15585/mmwr.mm6912e2 Ellinghaus, 2020, Genomewide association study of severe COVID-19 with respiratory failure, N Engl J Med McCrindle, 2017, Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association, Circulation, 135, e927, 10.1161/CIR.0000000000000484 Esper, 2005, Association between a novel human coronavirus and Kawasaki disease, J Infect Dis, 191, 499, 10.1086/428291 Ebihara, 2005, Lack of association between New Haven coronavirus and Kawasaki disease, J Infect Dis, 192, 351, 10.1086/430797 Belay, 2005, Kawasaki disease and human coronavirus, J Infect Dis, 192, 352, 10.1086/431609 Shimizu, 2005, Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease, J Infect Dis, 192, 1767, 10.1086/497170 Chang, 2006, Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan, J Infect Dis, 193, 283, 10.1086/498875 Dominguez, 2006, Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome, J Infect Dis, 194, 1697, 10.1086/509509 Kim, 2012, Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease, Korean J Pediatr, 55, 470, 10.3345/kjp.2012.55.12.470 Shirato, 2014, Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease, J Med Virol, 86, 2146, 10.1002/jmv.23950 Kim, 2014, Evaluation of the temporal association between Kawasaki disease and viral infections in South Korea, Korean Circ J, 44, 250, 10.4070/kcj.2014.44.4.250 Belot, 2020, SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020, Euro Surveill, 25, 10.2807/1560-7917.ES.2020.25.22.2001010 Woo, 2010, Coronavirus genomics and bioinformatics analysis, Viruses, 2, 1804, 10.3390/v2081803 Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570 de Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol, 14, 523, 10.1038/nrmicro.2016.81 Prompetchara, 2020, Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic, Asian Pac J Allergy Immunol, 39, 10 Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Hedrich, 2020, COVID-19—considerations for the paediatric rheumatologist, Clin Immunol, 214, 10.1016/j.clim.2020.108420 McGonagle, 2020, The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun Rev, 19, 10.1016/j.autrev.2020.102537 Atkin-Smith, 2018, The induction and consequences of influenza A virus-induced cell death, Cell Death Dis, 9, 10.1038/s41419-018-1035-6 Zhang, 2020, The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China, Clin Immunol, 214, 10.1016/j.clim.2020.108393 Li, 2020, SARS-CoV-2 and viral sepsis: observations and hypotheses, Lancet, 395, 1517, 10.1016/S0140-6736(20)30920-X Liu, 2020, Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients, EBioMedicine, 55, 10.1016/j.ebiom.2020.102763 Sardu, 2020, Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence, J Clin Med, 9, 10.3390/jcm9051417 Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5 Fuchs, 2007, Novel cell death program leads to neutrophil extracellular traps, J Cell Biol, 176, 231, 10.1083/jcb.200606027 Mozzini, 2020, The role of neutrophil extracellular traps in Covid-19: only an hypothesis or a potential new field of research?, Thromb Res, 191, 26, 10.1016/j.thromres.2020.04.031 Zuo, 2020, Neutrophil extracellular traps in COVID-19, JCI Insight, 5 Brill, 2012, Neutrophil extracellular traps promote deep vein thrombosis in mice, J Thromb Haemost, 10, 136, 10.1111/j.1538-7836.2011.04544.x Borissoff, 2013, Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state, Arterioscler Thromb Vasc Biol, 33, 2032, 10.1161/ATVBAHA.113.301627 Martinod, 2014, Thrombosis: tangled up in NETs, Blood, 123, 2768, 10.1182/blood-2013-10-463646 Selva, 2020, Distinct systems serology features in children, elderly and COVID patients, medRxiv Gruber, 2020, Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C), medRxiv Katzelnick, 2017, Antibody-dependent enhancement of severe dengue disease in humans, Science, 358, 929, 10.1126/science.aan6836 Endy, 2004, Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand, J Infect Dis, 189, 990, 10.1086/382280 Waggoner, 2020, Antibody-dependent enhancement of severe disease is mediated by serum viral load in pediatric dengue virus infections, J Infect Dis, 221, 1846, 10.1093/infdis/jiz618 Wang, 2014, Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins, Biochem Biophys Res Commun, 451, 208, 10.1016/j.bbrc.2014.07.090 Hoepel, 2020, Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses, bioRxiv Menikou, 2019, Kawasaki disease: the role of immune complexes revisited, Front Immunol, 10, 10.3389/fimmu.2019.01156 Mason, 1985, Circulating immune complexes in Kawasaki syndrome, Pediatr Infect Dis, 4, 48, 10.1097/00006454-198501000-00012 Ono, 1985, Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease, J Pediatr, 106, 567, 10.1016/S0022-3476(85)80073-1 Levin, 1985, Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis, Br Med J (Clin Res Ed), 290, 1456, 10.1136/bmj.290.6480.1456 Khor, 2011, Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease, Nat Genet, 43, 1241, 10.1038/ng.981 Lee, 2012, Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis, Nat Genet, 44, 522, 10.1038/ng.2227 Onouchi, 2004, CD40 ligand gene and Kawasaki disease, Eur J Hum Genet, 12, 1062, 10.1038/sj.ejhg.5201266 Onouchi, 2008, ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms, Nat Genet, 40, 35, 10.1038/ng.2007.59 Tremoulet, 2012, Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease, J Pediatr, 161, 506, 10.1016/j.jpeds.2012.02.048 Cheng, 2020, An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations, bioRxiv Deza Leon, 2020, COVID-19-associated pediatric multisystem inflammatory syndrome, J Pediatric Infect Dis Soc, 9, 407, 10.1093/jpids/piaa061 Hennon, 2020, COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach, Prog Pediatr Cardiol, 10.1016/j.ppedcard.2020.101232 Levin Beigel, 2020, Remdesivir for the treatment of COVID-19—preliminary report, N Engl J Med, 10.1056/NEJMoa2007764 Horby, 2020, Dexamethasone in hospitalized patients with COVID-19—preliminary report, N Engl J Med Levin, 2019, Effects of saline or albumin fluid bolus in resuscitation: evidence from re-analysis of the FEAST trial, Lancet Respir Med, 7, 581, 10.1016/S2213-2600(19)30114-6 Alhazzani, 2020, Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19), Crit Care Med, 48, e440, 10.1097/CCM.0000000000004363 Edwards, 1992, An experimental model for myocarditis and congestive heart failure after rabbit coronavirus infection, J Infect Dis, 165, 134, 10.1093/infdis/165.1.134 Mahmud, 2020, Management of acute myocardial infarction during the COVID-19 pandemic, J Am Coll Cardiol, 10.1016/j.jacc.2020.04.039 Caforio, 2013, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 34, 2636, 10.1093/eurheartj/eht210 Veronese, 2018, Fulminant myocarditis: characteristics, treatment, and outcomes, Anatol J Cardiol, 19, 279 Imazio, 2020, COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?, Heart, 106, 1127, 10.1136/heartjnl-2020-317186 Godfred-Cato, 2020, COVID-19–associated multisystem inflammatory syndrome in children — United States, March–July 2020, MMWR Morb Mortal Wkly Rep, 10.15585/mmwr.mm6932e2